Cargando…

Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach

SARS-CoV-2 infection produces a response of the innate immune system causing oxidative stress and a strong inflammatory reaction termed ‘cytokine storm’ that is one of the leading causes of death. Paraoxonase-1 (PON1) protects against oxidative stress by hydrolyzing lipoperoxides. Alterations in PON...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Tomàs, Elisabet, Iftimie, Simona, Castañé, Helena, Baiges-Gaya, Gerard, Hernández-Aguilera, Anna, González-Viñas, María, Castro, Antoni, Camps, Jordi, Joven, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234277/ https://www.ncbi.nlm.nih.gov/pubmed/34205807 http://dx.doi.org/10.3390/antiox10060991

Ejemplares similares

On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update
por: Camps, Jordi, et al.
Publicado: (2021)

Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19
por: Baiges-Gaya, Gerard, et al.
Publicado: (2023)

Measurement of Plasma Galectin-3 Concentrations in Patients with Catheter Infections: A Post Hoc Retrospective Cohort Study
por: Iftimie, Simona, et al.
Publicado: (2022)

Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients
por: Castañé, Helena, et al.
Publicado: (2022)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
por: Gabaldó, Xavier, et al.
Publicado: (2022)

Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet
por: Baiges-Gaya, Gerard, et al.
Publicado: (2022)

Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview
por: Castañé, Helena, et al.
Publicado: (2021)

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2019)

Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2022)

Gradient Boosting Machine Identified Predictive Variables for Breast Cancer Patients Pre- and Post-Radiotherapy: Preliminary Results of an 8-Year Follow-Up Study
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2022)

Can COVID-19 vaccines relieve severe tension-type headache and migraine?
por: González-Menacho, Jordi, et al.
Publicado: (2022)

Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2021)

Laparoscopic sleeve gastrectomy alters (1)H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease
por: Cabré, Noemí, et al.
Publicado: (2021)

Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging
por: Luciano-Mateo, Fedra, et al.
Publicado: (2020)

Chemokine C–C motif ligand 2 overexpression drives tissue-specific metabolic responses in the liver and muscle of mice
por: Luciano-Mateo, Fedra, et al.
Publicado: (2020)

First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain
por: Iftimie, Simona, et al.
Publicado: (2021)

Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain
por: Iftimie, Simona, et al.
Publicado: (2023)

Exploring the Role of Paraoxonases in the Pathogenesis of Coronary Artery Disease: A Systematic Review
por: Abelló, David, et al.
Publicado: (2014)

Characteristics of hospitalized patients with SARS-CoV-2 infection during successive waves of the COVID-19 pandemic in a reference hospital in Spain
por: Iftimie, Simona, et al.
Publicado: (2022)

PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
por: Camps, Jordi, et al.
Publicado: (2012)

The concentrations of essential/toxic elements in serum of COVID-19 patients are not directly related to the severity of the disease
por: Marquès, Montse, et al.
Publicado: (2023)

Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease
por: Hernández-Aguilera, Anna, et al.
Publicado: (2018)

Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease
por: Hernández-Aguilera, Anna, et al.
Publicado: (2015)

Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
por: Marsillach, Judit, et al.
Publicado: (2009)

Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients
por: Parra, Sandra, et al.
Publicado: (2010)

Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients
por: Arenas, Meritxell, et al.
Publicado: (2017)

Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain
por: Iftimie, Simona, et al.
Publicado: (2020)

Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010)

Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer’s Disease
por: Salazar, Jose Gregorio, et al.
Publicado: (2021)

Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis
por: Cabré, Noemí, et al.
Publicado: (2022)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Paraoxonase/MCS.
por: Rowat, S C
Publicado: (1999)

Introduction to Paraoxonases
por: Aviram, Michael
Publicado: (2012)

Homocysteinethiolactone and Paraoxonase: Novel markers of diabetic retinopathy
por: Barathi, Subramaniam, et al.
Publicado: (2010)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
por: Taler-Verčič, Ajda, et al.
Publicado: (2020)

Human paraoxonase 2
por: Porntadavity, Sureerut, et al.
Publicado: (2010)

Paraoxonase 1 and atherosclerosis
por: Durrington, Paul N., et al.
Publicado: (2023)

Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study
por: Riera-Borrull, Marta, et al.
Publicado: (2017)

Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation
por: Fort-Gallifa, Isabel, et al.
Publicado: (2017)

Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (or CCL2) in the Regulation of Metabolism
por: Rull, Anna, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mtchv8fq8efjjc6od1hnpi5mau